BFM
BLTE

Boothbay Fund Management’s Belite Bio BLTE Stock Holding History

Boothbay Fund Management’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
+12,733
New +$1.95M 0.03% 733
2026
Q1 		– Sell
-11,897
Closed -$1.9M – 2078
2025
Q4 		$1.9M Buy
+11,897
New +$1.41M 0.03% 579

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boothbay Fund Management's BLTE Position: Q2 2026 in Review

Boothbay Fund Management opened a new position in Belite Bio (BLTE) in Q2 2026: 12,733 shares worth $1.96M. The stake represents 0.03% of the portfolio and ranks #733 among its holdings. This is a return to the name: Boothbay Fund Management previously reported a position in BLTE as recently as Q4 2025.

Boothbay Fund Management first reported a position in BLTE in Q4 2025 and has held it in 2 quarters since. 80 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • Boothbay Fund Management held 12,733 shares of Belite Bio worth $1.96M as of Q2 2026.
  • Belite Bio was a new Boothbay Fund Management position in Q2 2026.
  • Belite Bio made up 0.03% of Boothbay Fund Management's portfolio in Q2 2026, its #733 holding.
  • Boothbay Fund Management first reported a position in Belite Bio in Q4 2025 and has held it in 2 quarters since.
  • 80 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.